Cargando…
Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy
SIMPLE SUMMARY: Near-infrared photoimmunotherapy (NIR-PIT) is a cancer therapy that selectively destroys target cells by first injecting monoclonal antibodies conjugated with a photon absorber (IRDye700DX) into the subject and then activating it at the tumor site by applying nonthermal doses of NIR...
Autores principales: | Furumoto, Hideyuki, Okada, Ryuhei, Kato, Takuya, Wakiyama, Hiroaki, Inagaki, Fuyuki, Fukushima, Hiroshi, Okuyama, Shuhei, Furusawa, Aki, Choyke, Peter L., Kobayashi, Hisataka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406827/ https://www.ncbi.nlm.nih.gov/pubmed/36011036 http://dx.doi.org/10.3390/cancers14164042 |
Ejemplares similares
-
Endoscopic near‐infrared photoimmunotherapy in an orthotopic head and neck cancer model
por: Okada, Ryuhei, et al.
Publicado: (2021) -
CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model
por: Furusawa, Aki, et al.
Publicado: (2022) -
Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin
por: Inagaki, Fuyuki F., et al.
Publicado: (2022) -
Intercellular adhesion molecule‐1‐targeted near‐infrared photoimmunotherapy of triple‐negative breast cancer
por: Fukushima, Hiroshi, et al.
Publicado: (2022) -
Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response
por: Kato, Takuya, et al.
Publicado: (2022)